Gut Fungus Linked to Reduced Alcohol Consumption in New Study
Table of Contents
A surprising connection between a common gut fungus and the brain’s reward system may offer new avenues for treating alcohol use disorder, which affects more than 5% of adults globally. Published in the journal mBio in 2025, research from Tufts University reveals that an overgrowth of Candida albicans can lead to decreased alcohol consumption in mice, potentially opening doors to novel therapeutic interventions.
The Unexpected Role of Gut Fungi
For years, the focus on the gut-brain axis has centered on bacteria. Though, this new study highlights the significant role fungi play in influencing behavior, specifically related to alcohol intake. Researchers discovered that when C. albicans, a fungus naturally residing in the human intestine, proliferates, it triggers an increase in prostaglandin E2 (PGE2), an inflammatory molecule.
“Our bodies are programmed so that our behavior responds to the gut microbiota, and this study highlights that fungi are important components of the gut-brain axis,” explained one author of the research.
How PGE2 Impacts the Brain’s Reward System
PGE2 is a versatile molecule involved in various bodily functions, including mediating inflammation, regulating stomach acidity, and triggering fever. The study demonstrates that when C. albicans flourishes – often linked to antibiotic use, poor diet, or alcohol consumption itself – it stimulates PGE2 production. This PGE2 then crosses the blood-brain barrier and impacts dopamine signaling in the dorsal striatum, a brain region crucial for reward processing and habit formation.
Initially, researchers hypothesized that mice colonized by C. albicans would find alcohol more rewarding and subsequently drink more. the results defied expectations. As PGE2 levels rose alongside fungal populations, the mice exhibited a clear avoidance of alcohol.Blocking the PGE2 receptor molecules reversed this behavior, causing the mice to resume drinking.
Implications for Human treatment
While the findings are based on animal models, they offer a compelling new perspective on the complexities of alcohol use disorder. The researchers acknowledge the need for further examination, noting that “this could be explained by differences in the response of mice to C. albicans compared to humans, differences in fungal strains, or perhaps we are seeing only a small part of the full story.”
The study also revealed that mice with C. albicans overgrowth displayed increased sensitivity to alcohol’s effects on motor coordination, an effect also reversible by blocking PGE2 activity. This suggests that fungal imbalances could influence not only the desire to drink but also the physical consequences of alcohol consumption.
The Future of Alcohol Use Disorder Treatment
Traditional treatments for alcohol use disorder – including behavioral therapy, support groups, medication, and abstinence maintenance – frequently enough yield moderate results, with high relapse rates remaining a significant challenge. This research underscores the potential of exploring option approaches that target the gut microbiome.
Recent clinical trials investigating fecal microbiota transplants for alcohol use disorder have shown promising preliminary results regarding alcohol preference and consumption. Further studies focusing on the interplay between fungi, PGE2, and the brain could unlock new factors contributing to the progression of this widespread disorder.
“We think that levels of fungal colonization in people with alcohol use disorder could be affecting host alcohol consumption by influencing interest in drinking; whether this affects satisfaction from a drink is more of an interpretation,” one researcher stated.This research represents a significant step toward understanding the intricate connection between the gut and the brain in the context of addiction.
